[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351451-105":59,"doc-detail-351451-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","emerging-role-of-lncrna-tp53tg1-as-a-tumor-regulator-and-biomarker-in-human-malignancies","Emerging role of lncRNA TP53TG1 as a tumor regulator and biomarker in human malignancies","","Long noncoding RNAs (lncRNAs) are RNA molecules longer than 200 nucleotides that do not encode proteins. Growing research focuses on tumor protein 53 target gene 1 (TP53TG1), a lncRNA located at 7q21.12, whose expression is altered across hepatocellular carcinoma, breast, gastric, non-small cell lung, colorectal, and glioma. TP53TG1 functions as a competitive endogenous RNA (ceRNA), modulating gene expression and regulating proliferation, migration, invasion, apoptosis, EMT, and drug resistance. The review evaluates TP53TG1’s expression, mechanisms, and clinical value as a prognostic biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/emerging-role-of-lncrna-tp53tg1-as-a-tumor-regulator-and-biomarker-in-human-malignancies/351451/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/emerging-role-of-lncrna-tp53tg1-as-a-tumor-regulator-and-biomarker-in-human-malignancies/351451.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is TP53TG1 and where is it located in the human genome?","Question",{"text":112,"@type":113},"TP53TG1 is a long noncoding RNA (lncRNA) located in the 7q21.12 chromosomal region. It does not encode proteins and exceeds 200 nucleotides.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does TP53TG1 contribute to cancer biology?",{"text":117,"@type":113},"TP53TG1 acts as a competitive endogenous RNA (ceRNA), affecting signaling pathways and gene expression. It influences proliferation, migration, invasion, apoptosis, EMT, and drug resistance.",{"name":119,"@type":110,"acceptedAnswer":120},"Why is TP53TG1 considered useful in clinical cancer management?",{"text":121,"@type":113},"Because TP53TG1 expression is altered in multiple tumor types and regulates key malignant behaviors, it is proposed as a biomarker for tumor prognosis and a potential therapeutic target.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351451,1790153542,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Wang et al. Discover Oncology (2026) 17:574 [https://doi.org/10.1007/s12672-026-04752-4](https://doi.org/10.1007/s12672-026-04752-4)  \nDiscover Oncology  \nREVIEW Open Access  \nEmerging role of lncRNA TP53TG1 asa tumor regulator and biomarker in human malignancies  \nBing Wang 1†, Tingting Yu2†, Lei Luo2, Wenqian Tang2 and Hua Zhang3*  \n†Bing Wang and Tingting Yu contributed equally to this work.  \n*Correspondence:  \nHua Zhang [13554493185@163.com](13554493185@163.com)[ ](13554493185@163.com)1Department of Respiratory and Critical Medicine, Jingmen Hospital of Traditional Chinese Medicine, Jingmen 448000, P. R. China 2Department of Health Management Center, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan 430070, P. R. China  \n3Department of Gastroenterology, Hubei Provincial Hospital of Integrated Chinese and Western Medicine, No. 11, Lingjiao Lake Road, Jianghan District,  \nWuhan City 430015, Hubei Province, P. R. China  \nAbstract  \nLong noncoding RNAs (lncRNAs) are a category of RNA molecules that exceed 200 nucleotides in length and do not possess the ability to encode proteins. Recently, there has been a growing interest among scientists regarding their functions and advancements in research. One notable lncRNA is the tumor protein 53 target gene 1 (TP53TG1), which has emerged in the last few years and is located in the chromosomal region 7q21 .12 of the human genome. Studies have increasingly pointed out the role ofTP53TG1 in the progression of various cancers, where its expression is altered in several tumors, including hepatocellular carcinoma, breast cancer, gastric cancer, non-small cell lung cancer, colorectal cancer, and glioma. Moreover, extensive research has shown that TP53TG1 acts as a competitive endogenous RNA (ceRNA), engaging in signaling pathways, modulating gene expression, and influencing the proliferation, migration, invasion, apoptosis, epithelialmesenchymal transition (EMT), and drug resistance of cancer cells. Consequently, TP53TG1 is posited as a significant biomarker for tumor prognosis and is anticipated to be a potentially effective target for cancer therapies. This review article examines the expression, biological roles, and molecular mechanisms ofTP53TG1 across various malignancies while exploring its clinical implications.  \nKeywords TP53TG1, Long non-coding RNAs, Cancer, Molecular mechanisms, Diagnosis, Prognosis  \n1 Introduction  \nDue to the elusive nature of cancer and its propensity to reappear, around 10 million people lose their lives to this disease worldwide each year [1]. According to the World Health Organization, it is estimated that by 2024, the yearly total of new cancer cases will climb to 28.9 million [2]. With increasing rates of incidence and mortality linked to cancer, it has become a major public health issue, placing considerable pressure on societies and healthcare systems across the globe. Tumor development results from a variety of factors, including genetic factors, nutritional practices, lifestyle decisions, and environmental conditions [3, 4]. Although there have been improvements in treatment  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/l](http://creative","cbCairKk2S97Jlh2","https://ap.wps.com/l/cbCairKk2S97Jlh2","pdf",2320488,"English","# Abstract\n# Keywords\n# 1 Introduction","[{\"question\":\"What is TP53TG1 and where is it located in the human genome?\",\"answer\":\"TP53TG1 is a long noncoding RNA (lncRNA) located in the 7q21.12 chromosomal region. It does not encode proteins and exceeds 200 nucleotides.\"},{\"question\":\"How does TP53TG1 contribute to cancer biology?\",\"answer\":\"TP53TG1 acts as a competitive endogenous RNA (ceRNA), affecting signaling pathways and gene expression. It influences proliferation, migration, invasion, apoptosis, EMT, and drug resistance.\"},{\"question\":\"Why is TP53TG1 considered useful in clinical cancer management?\",\"answer\":\"Because TP53TG1 expression is altered in multiple tumor types and regulates key malignant behaviors, it is proposed as a biomarker for tumor prognosis and a potential therapeutic target.\"}]","Emerging role of lncRNA TP53TG1 as a tumor regulator and biomarker in human malignancies | PDF",1790094249,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d91067a6b9d6cb15c73f35a52bd33d7.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6659eb9f6944636dc276741410e2df59.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9849961ececab0387d86cc04b2c484d6.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fda5c35d4d850b3f2f5ad6eb00b3aa54.webp",980,1306]